HemoSphereBio is proud to announce the official opening of its new state-of-the-art production facility, marking a major milestone in the company’s growth and manufacturing capabilities.
The new facility is equipped with cutting-edge technology designed to enhance production efficiency, ensure the highest quality standards, and support the scale-up of HemoSphereBio’s innovative therapies.
“This facility represents a significant investment in our future,” said CEO Viviane Cordura. “It allows us to expand our production capacity while maintaining the strictest quality and safety standards, ultimately enabling us to serve patients more effectively.”
The launch of this facility underscores HemoSphereBio’s commitment to innovation, operational excellence, and delivering advanced healthcare solutions to the global market.
Erstelle deine eigene Website mit Webador